“Long-Term Treatment with Adjunctive Cenobamate in Drug-Resistant Focal Epilepsy: Sustained Effectiveness and Safety in Polish Program”

https://pubmed.ncbi.nlm.nih.gov/38112647

The abstract reports that long-term treatment with adjunctive cenobamate in patients with drug-resistant focal epilepsy within the Polish Expanded Access Programme resulted in sustained effectiveness, high retention rate, and no new safety issues over 41 months.